Literature DB >> 21976120

[Recurrence prevention of urolithiasis with respect to economic aspects].

R Siener1, N Laube, W L Strohmaier.   

Abstract

Recurrence prevention in urinary stone disease not only makes good medical but also economic sense. Up to 40% of recurrences can be prevented by a rational urinary stone metaphylaxis whereby not only treatment costs but also the cost of lost productive work time can be saved. Detailed knowledge of stone composition and medical history of the patient is a prerequisite for a rational metaphylaxis which according to the S2 guidelines results in assignment to the high or low risk group. The required diagnostic and therapeutic measures are also decided by this classification. In addition to general metaphylaxis (reduction of overweight, physical activity, appropriate fluid intake, balanced diet) further specific measures may be necessary depending on the risk group and stone type.

Entities:  

Mesh:

Year:  2011        PMID: 21976120     DOI: 10.1007/s00120-011-2619-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  19 in total

1.  [Socioeconomic aspects of urinary calculi and metaphylaxis of urinary calculi].

Authors:  W L Strohmaier
Journal:  Urologe A       Date:  2000-03       Impact factor: 0.639

2.  Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000.

Authors:  A Hesse; E Brändle; D Wilbert; K-U Köhrmann; P Alken
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

3.  The effect of different diets on urine composition and the risk of calcium oxalate crystallisation in healthy subjects.

Authors:  Roswitha Siener; Albrecht Hesse
Journal:  Eur Urol       Date:  2002-09       Impact factor: 20.096

4.  The effect of fruits and vegetables on urinary stone risk factors.

Authors:  Tiziana Meschi; Umberto Maggiore; Enrico Fiaccadori; Tania Schianchi; Simone Bosi; Giuditta Adorni; Erminia Ridolo; Angela Guerra; Franca Allegri; Almerico Novarini; Loris Borghi
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

5.  [Current aspects of stone therapy].

Authors:  T Knoll; G Wendt-Nordahl; L Trojan; A Wenke; N Roeder; P Alken
Journal:  Aktuelle Urol       Date:  2005-02       Impact factor: 0.658

6.  [Economic aspects of evidence-based metaphylaxis].

Authors:  W L Strohmaier
Journal:  Urologe A       Date:  2006-11       Impact factor: 0.639

Review 7.  [Urinary tract infections and Urolithiasis].

Authors:  A Meissner; C Mamoulakis; N Laube
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

8.  Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria.

Authors:  Loris Borghi; Tania Schianchi; Tiziana Meschi; Angela Guerra; Franca Allegri; Umberto Maggiore; Almerico Novarini
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

9.  Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.

Authors:  Susanne Voss; Albrecht Hesse; Diana J Zimmermann; Tilman Sauerbruch; Gerd E von Unruh
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

10.  Dependence of oxalate absorption on the daily calcium intake.

Authors:  Gerd E von Unruh; Susanne Voss; Tilman Sauerbruch; Albrecht Hesse
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

View more
  3 in total

1.  Twenty-four-hour urine osmolality as a representative index of adequate hydration and a predictor of recurrence in patients with urolithiasis.

Authors:  Ho Won Kang; Sung Pil Seo; Yun-Sok Ha; Won Tae Kim; Yong-June Kim; Seok-Joong Yun; Wun-Jae Kim; Sang-Cheol Lee
Journal:  Int Urol Nephrol       Date:  2019-05-14       Impact factor: 2.370

2.  An empirical study on hospital-based prevention of recurrent urinary stone disease in Germany.

Authors:  Alina Reicherz; Patricia Rausch; Roman Herout; Joachim Noldus; Peter Bach
Journal:  World J Urol       Date:  2021-08-18       Impact factor: 4.226

3.  The efficacy of metaphylaxis in treatment of recurrent urolithiasis.

Authors:  P Banov; E Ceban
Journal:  J Med Life       Date:  2017 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.